Lung Tumor Articles & Analysis
2 articles found
Diffuse large b-cell lymphoma (DLBCL) is a highly aggressive and heterogeneous tumor that is the most common form of non-Hodgkin's lymphoma. With the development of novel targeted therapies, most patients with DLBCL can be cured. ...
Recently, Yang Hui, a researcher at Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, developed a nanofluidic chip technology to achieve high-throughput preparation of exosome drug carriers and experimentally verify the anti-tumor effect of novel exosome drug carriers. Exosomes are nanoscale particles that can be secreted into the extracellular space or ...